As the fall rate is expected to change with total time, the Andersen-Gill model with a single binary covariate indicating the randomized intervention will be applied, and the null hypothesis of no intervention effect, H0:{ β=0}, is to be tested at a two-sided significance level of 5%%.
A review of evaluation literature concerning CDSSs indicates that randomized controlled clinical trials (RCTs) are the 'gold standard' for evaluation.
When intermittent mechanical ventilation is indicated, a randomized study does not seem necessary before recommending first-line noninvasive ventilation rather than tracheotomy.
Mutagenesis of Pro was performed using synthetic double-stranded primers (sense primer, 5′-GCTAATTATGGGTTGCTGC NNNGGAGGAACTGGCTCC-3′; and antisense primer, 5′-GGAGCCAGTTCCTCC NNNGCAGCAACCCATAATTAGC-3′; where the underlined portions represent the Pro codon, and N indicates a randomized nucleotide).
Despite the pregabalin group being more severely affected at baseline, after 6 months of treatment they had a better quality of life gain than the group treated with SSRI/SNRI drugs, indicating that the randomized controlled trial did demonstrate a real-world clinical benefit for pregabalin, and appears to provide benefit additional to that seen in patient treated with SSRI/SNRI drugs.
As shown in Table 1, questions 5 and 28 exhibited greater infit MNSQ errors, indicating some non-randomized, or, say, unexpected aberrant responses on these two items.
However, relatively few patients have been included in randomized trials, indicating a need for more studies to secure valid conclusions.
Although there was no statistically significant improvement in live birth rates or implantation rates in this pilot study, there was a trend toward improved clinical outcomes, indicating that future multicenter randomized trials are needed.
However, available studies have limitations and it is not possible to recommend one exercise program over another, indicating a need for randomized controlled trials [ 6, 15].
There is substantial evidence from one randomized study indicating that rituximab maintenance significantly improves EFS in previously untreated patients who receive single-agent rituximab as induction therapy.
